Pharmiva AB (publ) (PHARM.ST)

STO Healthcare Biotechnology

Pharmiva AB (publ) operates in the Biotechnology industry of the Healthcare sector, headquartered in Lund, SE. The stock last traded at $0.56, down 16.17% on the session, giving a market capitalisation of $12.9M. Its beta of 1.56 implies it has historically moved more than the broad market.

Pharmiva AB (publ), a Swedish company based in Lund, specializes in the research and development of medical products. Its flagship product is Vernivia, an over-the-counter vaginal mousse formulated for the treatment of bacterial vaginosis.

Pharmiva AB (publ) is most often compared with the following Healthcare names: